• The Search for Effective Treatments for Canine Inflammatory Brain Disease

    February 7, 2022

    Ethos Discovery hopes that NME will become a disease that no longer carries such a devastating prognosis and is instead associated with the ability for early diagnosis and preventative treatment options. A possible inflammatory-mediating treatment that we have identified for the treatment of NME in dogs is the administration of mesenchymal stem cells.

    Read Article
  • Provocative Question: “Does the Gut Microbiome Influence the Metastatic Cascade of Cancer?”

    August 16, 2021

    The mechanisms by which the microbiota may influence metastasis and the break in dormancy may uncover therapeutic and prognostic tools useful in improving outcomes for cancer patients.

    Read Article
  • The Ethos Discovery Approach to Scientific Innovation

    July 16, 2021

    Ethos Discovery is committed to the process of starting with an unmet clinical need to determine trial prioritization for both basic research as well as later stage research. Through this “unmet need” approach, we expect to deliver cures to diseases such as canine hemangiosarcoma, sepsis, and other complex medical problems in pet animals.

    Read Article
  • Ethos-PUSH – Studying the Genome and Epigenetic Alterations

    June 30, 2021

    Through the Ethos-PUSH study we will be studying genetic and epigenetic alterations in tumor samples with the goal of proposing novel therapeutic options, that will be vital in curing hemangiosarcoma in dogs.

    Read Article
  • surgeon performing minimally invasive surgery

    Minimally invasive surgery and the GP: Getting started

    June 23, 2021

    Veterinary surgeon Chris Thomson answers some common questions regarding learning curves, feasibility, how to get started, and basic equipment needs for a veterinarian in general practice, to make the leap into the world of minimally invasive surgery.

    Read Article
  • The Microbiome as a Functional Organ

    June 2, 2021

    Ethos Discovery's ultimate goal is to discover and develop novel diagnostics and therapeutics for intestinal dysbiosis, and ultimately to be able to predict and even prevent certain chronic diseases. This will lead to prolonged lifespan and health-span for domestic animals and also for human beings.

    Read Article
  • Ethos Discovery vs Canine Hemangiosarcoma

    February 12, 2021

    Ethos-PUSH will serve as the largest collection of canine hemangiosarcoma biospecimens in the world. These biospecimens will be made available to independent collaborators with the goal of further understanding the genomics, epigenomics, and biology of hemangiosarcoma.

    Read Article
  • Yellow lab on grass with ball

    Diagnosis, Treatment and Future Study Direction in Dogs with Intestinal Dysbiosis

    September 11, 2020

    A patient with intestinal dysbiosis can have decreased appetite, diarrhea, vomiting, or a variety of other clinical signs.

    Read Article
  • Hemangiosarcoma – Developing New Treatment Options

    August 12, 2020

    Ethos Discovery hopes to improve the outcome for dogs with hemangiosarcoma and take a similar path as to that of human childhood leukemia, which through significant research efforts went from a commonly fatal disease to a commonly cured disease.

    Read Article
  • Rachael Ray Drs. Chand Khanna and William Li interview cancer and Isaboo

    Rachael Ray Talks to Dr. Khanna

    June 18, 2020

    Dr. Chand Khanna, joined Rachael Ray and internal medicine specialist Dr. William Li to talk about the bridge between animal and human health, and how research for one can positively impact the other

    Read Article
  • Improving Survival Rates in Septic Patients

    June 11, 2020

    Sepsis is the result of an infection that enters the bloodstream and causes a severe inflammatory reaction. It can lead to many alterations around the body that can cause significant difficulty in the diagnosis and treatment of the underlying infection. Ethos Discovery hopes that its research will contribute to an improvement in patient survival rates, which would not only be beneficial to veterinary patients, but to human patients as well.

    Read Article
  • How Hemangiosarcoma Broke Our Hearts

    May 27, 2020

    We hope that Dakota’s story helps those who are unfamiliar with the rapid progression of Hemangiosarcoma to better understand it.

    Read Article
Load More